Drug-induced interstitial lung disease in patients with non-small cell lung cancer treated with immunotherapy for postoperative recurrence: Evaluation of CT findings and histopathological findings of the background lung

被引：0
|
作者：
Fujimoto, S. [1 ]
Tanaka, T. [2 ]
Katsurada, N. [1 ]
Hazama, D. [1 ]
Nagano, T. [1 ]
Yamamoto, M. [1 ]
Tachihara, M. [1 ]
机构：
[1] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Resp Med, Kobe, Hyogo, Japan
[2] Kobe Univ, Grad Sch Med, Dept Diagnost Pathol, Kobe, Hyogo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.628
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
549P
引用
收藏
页码：S1683 / S1684
页数：2
相关论文
共 50 条
  • [41] An evaluation of the association between molecular signature and postoperative recurrence in patients with non-small cell lung cancer
    Ono, A.
    Serizawa, M.
    Isaka, M.
    Kojima, H.
    Takahashi, S.
    Nakashima, K.
    Omori, S.
    Wakuda, K.
    Kenmotsu, H.
    Naito, T.
    Murakami, H.
    Urakami, K.
    Ohde, Y.
    Nakajima, T.
    Kusuhara, M.
    Takahashi, T.
    Yamaguchi, K.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S46 - S46
  • [42] Radiation therapy in patients with non-small cell lung cancer and interstitial lung abnormalities
    Ito, M.
    Katano, T.
    Okada, H.
    Sakuragi, A.
    Minami, Y.
    Abe, S.
    Adachi, S.
    Oshima, Y.
    Kubo, A.
    Fukui, T.
    Ito, S.
    Suzuki, K.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1073 - S1074
  • [43] Prognostic factors for gefitinib-treated postoperative recurrence in non-small cell lung cancer
    Okami, Jiro
    Taniguchi, Kazuya
    Higashiyama, Masahiko
    Maeda, Jun
    Oda, Kazuyuki
    Orita, Naoki
    Koizumi, Kyoko
    Kodama, Ken
    Kato, Kikuya
    ONCOLOGY, 2007, 72 (3-4) : 234 - 242
  • [44] Interstitial lung disease in patients with small cell lung cancer
    Miyazaki, Kunihiko
    Satoh, Hiroaki
    Kurishima, Koichi
    Nakamura, Ryota
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Hizawa, Nobuyuki
    MEDICAL ONCOLOGY, 2010, 27 (03) : 763 - 767
  • [45] Interstitial lung disease in patients with small cell lung cancer
    Kunihiko Miyazaki
    Hiroaki Satoh
    Koichi Kurishima
    Ryota Nakamura
    Hiroichi Ishikawa
    Katsunori Kagohashi
    Nobuyuki Hizawa
    Medical Oncology, 2010, 27 : 763 - 767
  • [46] Lung Immune Prognostic Index in Patients with Non-small Cell Lung Cancer Treated with Either Chemo or Immunotherapy
    Barron, F.
    Mota, B.
    Ramirez Tirado, L. A.
    Zatarain Barron, L.
    Lopez, D.
    Peralta Alvarez, M. P.
    Arrieta, O.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1195 - S1195
  • [47] Neoadjuvant Immunotherapy for Patients with non-small cell Lung Cancer
    Luecke, E.
    Ganzert, C.
    Waesche, A.
    Walles, T.
    Schreiber, J.
    PNEUMOLOGIE, 2020, 74 : S74 - S75
  • [48] Immunotherapy in previously treated non-small cell lung cancer (NSCLC)
    Leal, Ticiana A.
    Ramalingam, Suresh S.
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S422 - S432
  • [49] Interstitial Lung Disease Induced by Crizotinib in Non-Small-Cell Lung Cancer
    Tereso, Andreia
    Carreto, Luis
    Baptista, Manuela
    Almeida, Maria Amelia
    ACTA MEDICA PORTUGUESA, 2019, 32 (03): : 236 - 239
  • [50] Integrated imaging of non-small cell lung cancer recurrence: CT and PET-CT findings, possible pitfalls and risk of recurrence criteria
    Andrea Caulo
    Saeed Mirsadraee
    Fabio Maggi
    Lucia Leccisotti
    Edwin J. R. van Beek
    Lorenzo Bonomo
    European Radiology, 2012, 22 : 588 - 606
12345